Treating Oxidative Stress in Children With Autism

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

December 31, 2007

Conditions

Autistic Disorder

Interventions

DRUG

Methylcobalamin (methylB12)

75 ug/Kg methylB12 every 3 days by subcutaneous injection

Trial Locations (1)

Arkansas Children's Hospital Research Institute, Little Rock

All Listed Sponsors

lead

Arkansas Children's Hospital Research Institute

OTHER

NCT00692315 - Treating Oxidative Stress in Children With Autism | Biotech Hunter | Biotech Hunter